Fintel reports that on November 20, 2025, Benchmark maintained coverage of Milestone Scientific (NYSEAM:MLSS) with a Speculative Buy recommendation. Analyst Price Forecast Suggests 537.50% Upside As ...
Benchmark noted that steady growth in Milestone’s dental business provides a foundation for future revenue expansion as the company continues developing its medical segment for pain management with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results